JBPOS0101 is an investigational drug under study for the treatment of refractory infantile spasms and status epilepticus, acting as a modulator of metabotropic glutamate receptors. Its therapeutic use is listed as central nervous system (CNS) agents. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include CHEMBL4594413 and SCHEMBL29982650. Its PubChem CID is 57524523.
Jbpos-0101
| CAS No | 1353949-71-9 |
|---|---|
| Molecular Formula | C10H12ClNO3 |
| Molecular Weight | 229.66 g/mol |
| Synonyms | [(1S,2S)-1-(2-chlorophenyl)-1-hydroxypropan-2-yl] carbamate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
JBPOS0101 is an investigational drug under study for the treatment of refractory infantile spasms and status epilepticus, acting as a modulator of metabotropic glutamate receptors.
The listed CAS number is 1353949-71-9.
The listed molecular formula is C10H12ClNO3.
The listed molecular weight is 229.66 g/mol.
[(1S,2S)-1-(2-chlorophenyl)-1-hydroxypropan-2-yl] carbamate.
The source lists CHEMBL4594413 and SCHEMBL29982650.